The KRT17 gene helps make a tough structural protein that supports nails, hair follicles, and the outer layer of skin. This gene plays an important role in helping these tissues handle friction and repair. If the KRT17 gene does not work properly, you may develop thick nails, painful thickened skin on the soles or palms, and cysts. Pathogenic variants in the KRT17 gene are linked to pachyonychia congenita, a rare inherited skin condition.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or manage processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
KRT17Gene function
What if the gene works
The KRT17 gene helps make keratin 17, a protein that gives strength to skin, hair follicles, and nails. It also supports wound healing and the normal growth of certain skin cells.
Risk
What if the gene does not work
Variants in the KRT17 gene most often affect nails and skin, causing thick nails, painful thickened soles, and skin cysts; some people also have teeth present at birth. Milder to more severe variants can shift onset and severity.
Treatment
What does that mean for your treatment
No KRT17-specific treatment or drug selection is currently established for pathogenic or loss-of-function variants in the KRT17 gene, so care is based on a person’s symptoms rather than the variant itself. The KRT17 gene is being studied as a biomarker and possible drug target in some cancers.
Conditions associated with KRT17
Gene function
What if the gene works
Your cells use the KRT17 gene to make keratin 17, a sturdy protein in skin, hair follicles, and nails. It helps build the inner support fibers that keep these tissues flexible but strong. This explains what the KRT17 gene does in skin and hair during everyday growth and wear.
The KRT17 gene helps certain skin cells build flexible inner fibers. These fibers act like cables, helping cells keep their shape during rubbing, pressure, and stretching.
In hair follicles, keratin 17 is part of the framework around growing hair. It supports the structure of follicle cells as hair forms and moves through normal growth cycles.
In the nail bed, this protein helps create the strong cell framework that supports nail formation. That framework helps the tissue under the nail stay organized as the nail grows forward.
Keratin 17 works with other keratin proteins in glands and at the base of hair follicles. Together they form a resilient network that helps these tissues handle everyday friction.
What is a variant?
Genetic variants are small differences in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental factors. Many variants do not cause any noticeable effects and are simply part of natural genetic variation. In some situations, though, a variant can more strongly affect how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KRT17 gene often change the keratin 17 protein so it cannot link properly with partner proteins, which weakens the cell’s internal support network. Some altered proteins also interfere with the normal protein, so KRT17 gene variants linked to pachyonychia congenita can have effects that are stronger than simple loss of protein. Milder variants may disturb fiber assembly only partly, while more disruptive variants can cause earlier or more marked nail and skin changes.
How variants are linked to conditions
Pathogenic variants in the KRT17 gene can cause pachyonychia congenita, especially a form often called type 2, which is linked to thick nails, painful soles, skin cysts, and sometimes teeth present at birth. Variants in the KRT17 gene are also associated with steatocystoma multiplex, a condition with many skin cysts that may occur on its own or as part of the same clinical spectrum.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common across the general population. Most have no direct impact on health and simply reflect natural variation among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For disease-causing changes in the KRT17 gene, the main driver of risk is the variant itself, often inherited in families. Day-to-day factors such as repeated friction, pressure, and heat can make symptoms worse, especially painful thick skin on the feet, but they do not change whether the gene-related condition is present.
Inheritance of KRT17 variants
KRT17-related conditions are usually inherited in an autosomal dominant pattern, which means a child can inherit the gene change from one affected parent. In practical terms, the KRT17 inheritance pattern gives each child a 50% chance of inheriting the variant. Some people with a KRT17 variant are the first in their family to have it because the change arose new in them and was not passed down by either parent. A parent of any sex can pass it to a son or a daughter.
What does my KRT17 result mean for my family?
A harmful change in the KRT17 gene is usually passed down in a dominant pattern, so close relatives such as a parent, brother, sister, or child may also have the same change and may have similar nail, skin, or cyst problems. Each child of someone with a KRT17-related condition has a 1 in 2, or 50%, chance of inheriting it. Some cases happen for the first time in one person, so a parent does not always have the gene change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for KRT17 variants uses blood, saliva, or a cheek swab to look for changes in the KRT17 gene. A lab reads the DNA code and compares it with the usual sequence to see whether a variant is present. Results can help confirm whether the gene change found in a family is the same one you carry.
When should I consider getting a genetic test?
Genetic testing for the KRT17 gene may be worth considering if someone has very thick or misshapen nails from childhood, painful calluses on the soles, skin cysts, or close relatives with the same pattern. A result can help confirm the cause and show whether the condition may run in the family.
A genetic result is only one part of your health story
A genetic result can be very informative, but how much it reveals depends on the condition and on the kind of variant involved. Factors such as lifestyle, environment, age, and medical history also shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some gene changes influence how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, do less for another, or cause more side effects in someone else. These differences are common and are one part of why treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics focuses on how genetic differences can shape a person’s response to medications. It examines links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the KRT17 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or response, so questions about medicines, side effects, or other health concerns are best discussed with your doctor.
History
KRT17 came into focus as researchers mapped the growing keratin gene family in the late 20th century and sorted out which keratins were active in different tissues. Early work showed that KRT17 was part of the pattern seen in hair follicles, nails, and certain skin glands. From these first observations, research expanded steadily. In the 1990s, variants in the KRT17 gene were linked to pachyonychia congenita type 2, helping connect a visible inherited condition with a specific genetic cause. KRT17 variants were also identified in some families with steatocystoma multiplex, which clarified why these conditions can overlap. These findings helped shape modern classification of inherited skin and nail conditions and made KRT17 an established part of dermatology genetics.